BSE Live
Jun 05, 16:01Prev. Close
240.40
Open Price
242.30
Bid Price (Qty.)
241.40 (1)
Offer Price (Qty.)
241.40 (45)
NSE Live
Jun 05, 15:59Prev. Close
240.25
Open Price
242.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
241.40 (7177)
Profit & Loss account of Biocon (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 11,174.20 | 8,184.00 | 6,970.10 | 6,144.80 | 5,381.10 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 11,174.20 | 8,184.00 | 6,970.10 | 6,144.80 | 5,381.10 | |
Total Operating Revenues | 11,174.20 | 8,184.00 | 7,105.80 | 6,300.50 | 5,514.40 | |
Other Income | 375.90 | 212.70 | 254.50 | 161.40 | 144.40 | |
Total Revenue | 11,550.10 | 8,396.70 | 7,360.30 | 6,461.90 | 5,658.80 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 3,191.10 | 2,813.90 | 2,430.20 | 2,104.90 | 2,029.90 | |
Purchase Of Stock-In Trade | 626.10 | 161.10 | 68.40 | 85.40 | 76.40 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | -154.10 | -256.60 | -290.10 | -200.80 | -209.70 | |
Employee Benefit Expenses | 2,181.00 | 1,880.10 | 1,741.00 | 1,458.80 | 1,165.30 | |
Finance Costs | 419.00 | 67.60 | 57.70 | 64.90 | 70.90 | |
Depreciation And Amortisation Expenses | 1,113.10 | 814.20 | 715.10 | 552.20 | 447.80 | |
Other Expenses | 2,818.40 | 2,091.70 | 1,503.70 | 1,249.10 | 1,328.70 | |
Total Expenses | 10,194.60 | 7,095.60 | 6,226.00 | 5,314.50 | 4,639.40 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,355.50 | 1,301.10 | 1,134.30 | 1,147.40 | 1,019.40 | |
Exceptional Items | -291.40 | -111.10 | 12.60 | 67.50 | 194.60 | |
Profit/Loss Before Tax | 1,064.10 | 1,190.00 | 1,146.90 | 1,214.90 | 1,214.00 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 254.10 | 220.40 | 196.60 | 271.30 | 203.80 | |
Less: MAT Credit Entitlement | 0.00 | -23.50 | 25.90 | 37.40 | 13.80 | |
Deferred Tax | 0.00 | -32.40 | 50.80 | 81.20 | 22.30 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 254.10 | 211.50 | 221.50 | 315.10 | 212.30 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 810.00 | 978.50 | 925.40 | 899.80 | 1,001.70 | |
Profit/Loss From Continuing Operations | 810.00 | 978.50 | 925.40 | 899.80 | 1,001.70 | |
Profit/Loss For The Period | 810.00 | 978.50 | 915.70 | 870.90 | 1,001.70 | |
Minority Interest | -180.30 | -123.20 | -105.70 | -122.70 | -97.30 | |
Consolidated Profit/Loss After MI And Associates | 462.70 | 648.40 | 740.50 | 748.20 | 905.30 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 4.00 | 5.00 | 6.00 | 6.00 | 8.00 | |
Diluted EPS (Rs.) | 4.00 | 5.00 | 6.00 | 6.00 | 8.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 63.00 | 72.20 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
24.05.2023
Biocon Consolidated March 2023 Net Sales at Rs 3,773.90 crore, up 56.67% Y-o-Y
24.05.2023
Biocon Standalone March 2023 Net Sales at Rs 506.70 crore, down 2.12% Y-o-Y
23.05.2023
Biocon Q4 net profit rises 31% to Rs 313 crore; declares dividend
20.02.2023
Biocon Standalone December 2022 Net Sales at Rs 555.00 crore, up 17.34% Y-o-Y